NASDAQ:IBBiShares Nasdaq Biotechnology ETF Stock Price, Forecast & News

iShares Nasdaq Biotechnology ETF's stock was trading at $106.97 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IBB stock has increased by 33.2% and is now trading at $142.46. View which stocks have been most impacted by Coronavirus.

iShares Nasdaq Biotechnology ETF declared a quarterly dividend on Wednesday, March 25th. Shareholders of record on Thursday, March 26th will be given a dividend of $0.0554 per share on Tuesday, March 31st. This represents a $0.22 annualized dividend and a dividend yield of 0.16%. The ex-dividend date is Wednesday, March 25th. View iShares Nasdaq Biotechnology ETF's dividend history.

Shares of iShares Nasdaq Biotechnology ETF split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly minted shares were payable to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split.

News stories about IBB stock have been trending very negative on Monday, InfoTrie reports. The research group ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. iShares Nasdaq Biotechnology ETF earned a media sentiment score of -3.2 on InfoTrie's scale. They also gave news coverage about the financial services provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about iShares Nasdaq Biotechnology ETF.

Some companies that are related to iShares Nasdaq Biotechnology ETF include DNP Select Income Fund (DNP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), PIMCO Corporate&Income Opportunity Fund (PTY), Tri-Continental (TY), Gabelli Equity Trust (GAB), Liberty All-Star Equity Fund (USA), Royce Value Trust (RVT), Hercules Capital (HTGC), Boulder Growth & Income Fund (BIF), Blackrock Muniyield Insured Fund (MYI), Tekla Healthcare Investors (HQH), AllianceBernstein Global Hgh Incm Fd (AWF), Tortoise Energy Infrastructure (TYG) and Invesco Van Kampen Munpl Oprtnty Tr (VMO). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Nasdaq Biotechnology ETF investors own include NVIDIA (NVDA), Alibaba Group (BABA), Walt Disney (DIS), Netflix (NFLX), Bank of America (BAC), Tesla (TSLA), Cisco Systems (CSCO), Gilead Sciences (GILD), Micron Technology (MU) and Boeing (BA).

iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

iShares Nasdaq Biotechnology ETF's stock is owned by many different retail and institutional investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.60%), Chesley Taft & Associates LLC (0.06%), M&R Capital Management Inc. (0.05%), EWG Elevate Inc. (0.04%), Burns J W & Co. Inc. NY (0.04%) and Bay Rivers Group (0.03%).

IBB stock was sold by a variety of institutional investors in the last quarter, including Fulton Bank N. A., Ellis Investment Partners LLC, Clarus Wealth Advisors, Chesley Taft & Associates LLC, Wiley BROS. Aintree Capital LLC, Acorn Financial Advisory Services Inc. ADV, Whittier Trust Co. of Nevada Inc., and Burns J W & Co. Inc. NY.

IBB stock was acquired by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., EWG Elevate Inc., Platte River Wealth Advisors LLC, Tatro Capital LLC, M&R Capital Management Inc., Carroll Financial Associates Inc., N.E.W. Advisory Services LLC, and Tsfg LLC.

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of IBB stock can currently be purchased for approximately $142.46.

iShares Nasdaq Biotechnology ETF has a market capitalization of $10.11 billion.